Author： Beier Manju Panchapagesan Madhumitha Carman Ladd
Publisher： American Society of Consultant Pharmacists
ISSN： 0888-5109
Source： The Consultant Pharmacist, Vol.28, Iss.11, 2013-11, pp. : 696-711
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 1, 2012-03 ,pp. :
Pharmacists must embrace outcomes research
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 262, 2000-01 ,pp. :
Individual bioequivalence-has its time come?
European Journal of Pharmaceutical Sciences, Vol. 6, Iss. 4, 1998-10 ,pp. :
Predictive Molecular Markers: Has the Time Come for Routine Use in Lung Cancer?
By Davies Angela M. Mack Philip C. Lara Primo N. Lau Derick H. Danenberg Kathleen Gumerlock Paul H. Gandara David R.
Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 2, 2004-03 ,pp. :
Cambridge Scholars Publishing in association with GSE Research